Medidata Solutions ROA 2009-2018 | MDSO

Current and historical return on assets (ROA) values for Medidata Solutions (MDSO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Medidata Solutions ROA for the three months ending September 30, 2018 was 5.69%.
Medidata Solutions ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $0.05B $0.87B 5.06%
2018-06-30 $0.05B $1.10B 5.20%
2018-03-31 $0.05B $1.08B 4.57%
2017-12-31 $0.05B $1.06B 4.88%
2017-09-30 $0.04B $0.91B 4.87%
2017-06-30 $0.04B $0.89B 4.34%
2017-03-31 $0.03B $0.83B 4.33%
2016-12-31 $0.03B $0.82B 3.88%
2016-09-30 $0.03B $0.79B 3.50%
2016-06-30 $0.02B $0.71B 3.34%
2016-03-31 $0.02B $0.67B 2.80%
2015-12-31 $0.01B $0.68B 2.09%
2015-09-30 $0.01B $0.68B 1.83%
2015-06-30 $0.01B $0.67B 1.11%
2015-03-31 $0.01B $0.64B 1.16%
2014-12-31 $0.01B $0.62B 0.85%
2014-09-30 $0.00B $0.59B 0.17%
2014-06-30 $0.01B $0.57B 1.07%
2014-03-31 $0.01B $0.56B 1.87%
2013-12-31 $0.02B $0.57B 4.28%
2013-09-30 $0.02B $0.55B 7.41%
2013-06-30 $0.02B $0.24B 9.69%
2013-03-31 $0.02B $0.23B 9.59%
2012-12-31 $0.02B $0.23B 8.97%
2012-09-30 $0.03B $0.21B 15.27%
2012-06-30 $0.03B $0.21B 17.75%
2012-03-31 $0.04B $0.20B 22.35%
2011-12-31 $0.04B $0.19B 23.18%
2011-09-30 $0.03B $0.17B 20.59%
2011-06-30 $0.03B $0.16B 19.97%
2011-03-31 $0.02B $0.16B 15.89%
2010-12-31 $0.02B $0.16B 15.73%
2010-09-30 $0.01B $0.15B 8.42%
2010-06-30 $0.01B $0.14B 6.38%
2010-03-31 $0.01B $0.14B 4.19%
2009-12-31 $0.01B $0.14B 5.53%
2009-09-30 $0.00B $0.14B 5.50%
2009-06-30 $-0.00B $0.15B -2.65%
2009-03-31 $-0.01B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $4.433B $0.546B
Medidata Solutions is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers' clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer), investigator benchmarking and budgeting (Medidata Grants Manager), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave). Medidata's diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes some top global pharmaceutical companies.
Stock Name Country Market Cap PE Ratio
Cerner (CERN) United States $19.074B 26.68
Athenahealth (ATHN) United States $5.336B 36.40
HMS Holdings Corp (HMSY) United States $3.121B 48.30
Omnicell (OMCL) United States $2.886B 63.88
IRHYTHM TECH (IRTC) United States $1.796B 0.00
Allscripts Healthcare Solutions (MDRX) United States $1.793B 20.12
Tabula Rasa Healthcare (TRHC) United States $1.362B 190.20
Quality Systems (NXGN) United States $1.025B 30.48
Invitae (NVTA) United States $0.988B 0.00
Inspire Medical Systems (INSP) $0.970B 0.00
111 Sponsored ADR (YI) China $0.817B 0.00
AXONICS MODULTN (AXNX) United States $0.401B 0.00
Computer Programs And Systems (CPSI) United States $0.359B 14.47
NantHealth (NH) United States $0.150B 0.00
Strata Skin Sciences (SSKN) United States $0.078B 0.00
FULGENT GENETIC (FLGT) United States $0.060B 0.00
Motus GI Holdings (MOTS) United States $0.053B 0.00
Digirad (DRAD) United States $0.021B 0.00
Streamline Health Solutions (STRM) United States $0.018B 0.00
Transgenomic (PRPO) United States $0.007B 0.00